+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Genomics Market Report and Forecast 2023-2028

  • PDF Icon

    Report

  • 173 Pages
  • August 2023
  • Region: Global
  • Expert Market Research
  • ID: 5869254
According to the report the global genomics market reached a value of USD 19.6 billion in 2022. Aided by the rapid technological advancements in DNA sequencing and an ever-growing demand for personalised medicine, the market is projected to further grow at a CAGR of 9.5% between 2023 and 2028.

Genomics refers to the study of genomes, the complete set of genes within an organism. It encompasses a variety of techniques, including sequencing, analysis, and editing, to understand, treat, or prevent diseases at their genetic roots. As the foundational science of the 21st century, genomics holds transformative potential across healthcare, agriculture, pharmaceuticals, and even biotechnology sectors.

The accelerating transition towards personalised medicine is one of the key genomics market trends driving the market. As healthcare systems and professionals aim to tailor treatments and interventions to individual genetic profiles, there is a soaring demand for genomic data. Personalised medicine relies heavily on understanding one's genomic information to predict susceptibility to certain diseases or determine the best therapeutic approach, making genomics indispensable.

Another pivotal growth determinant is the rapid decline in the cost of DNA sequencing. Earlier, sequencing the human genome was a billion-dollar venture; now, it's within the reach of many. This dramatic reduction in cost, combined with increasing accuracy and speed, has democratised access to genomic information, leading to its widespread application in clinical settings.

Yet, the application of genomics isn't limited to human health alone. The genomics market demand is witnessing a surge in several other sectors. In agriculture, for instance, genomics plays a crucial role in breeding improved plant varieties with desired traits. Similarly, in the pharmaceutical sector, genomics assists in drug discovery, ensuring that new treatments are both effective and safe.

Furthermore, there's a global thrust towards integrating genomics into mainstream healthcare. From cancer treatments to rare disease diagnostics, genomics promises a paradigm shift. Educational initiatives, aimed at both healthcare professionals and the general public, are ensuring that the benefits of genomics are well-understood and well-utilised. In geographical terms, North America holds a significant portion of the genomics market share.

Market Segmentation

The market can be divided based on product, technology, application, end use, and region.

Market Breakup by Product

  • Consumables
  • Systems and Software
  • Services

Market Breakup by Technology

  • PCR
  • Sequencing
  • Microarray
  • Nucleic Acid Extraction and Purification
  • Others

Market Breakup by Application

  • Diagnostics
  • Drug Discovery and Development
  • Precision Medicine
  • Agriculture and Animal Research
  • Others

Market Breakup by End Use

  • Research Centres and Academic and Government Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape

The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global genomics market. Some of the major players explored in the report are as follows:
  • Illumina, Inc.
  • QIAGEN GmbH
  • Eurofins GSC Lux SARL
  • Agilent Technologies, Inc.
  • Oxford Nanopore Technologies Limited
  • F. Hoffmann-La Roche
  • Bio-Rad Laboratories, Inc.
  • BGI Group
  • Others

About the Publisher

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation's future success by acquiring one of these reports today.

*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Genomics Market Analysis
8.1 Key Industry Highlights
8.2 Global Genomics Historical Market (2018-2022)
8.3 Global Genomics Market Forecast (2023-2028)
8.4 Global Genomics Market by Product
8.4.1 Consumables
8.4.1.1 Historical Trend (2018-2022)
8.4.1.2 Forecast Trend (2023-2028)
8.4.2 Systems and Software
8.4.2.1 Historical Trend (2018-2022)
8.4.2.2 Forecast Trend (2023-2028)
8.4.3 Services
8.4.3.1 Historical Trend (2018-2022)
8.4.3.2 Forecast Trend (2023-2028)
8.5 Global Genomics Market by Technology
8.5.1 PCR
8.5.1.1 Historical Trend (2018-2022)
8.5.1.2 Forecast Trend (2023-2028)
8.5.2 Sequencing
8.5.2.1 Historical Trend (2018-2022)
8.5.2.2 Forecast Trend (2023-2028)
8.5.3 Microarray
8.5.3.1 Historical Trend (2018-2022)
8.5.3.2 Forecast Trend (2023-2028)
8.5.4 Nucleic Acid Extraction and Purification
8.5.4.1 Historical Trend (2018-2022)
8.5.4.2 Forecast Trend (2023-2028)
8.5.5 Others
8.6 Global Genomics Market by Application
8.6.1 Diagnostics
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Drug Discovery and Development
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 Precision Medicine
8.6.3.1 Historical Trend (2018-2022)
8.6.3.2 Forecast Trend (2023-2028)
8.6.4 Agriculture and Animal Research
8.6.4.1 Historical Trend (2018-2022)
8.6.4.2 Forecast Trend (2023-2028)
8.6.5 Others
8.7 Global Genomics Market by End Use
8.7.1 Research Centres and Academic and Government Institutes
8.7.1.1 Historical Trend (2018-2022)
8.7.1.2 Forecast Trend (2023-2028)
8.7.2 Hospitals and Clinics
8.7.2.1 Historical Trend (2018-2022)
8.7.2.2 Forecast Trend (2023-2028)
8.7.3 Pharmaceutical and Biotechnology Companies
8.7.3.1 Historical Trend (2018-2022)
8.7.3.2 Forecast Trend (2023-2028)
8.7.4 Others
8.8 Global Genomics Market by Region
8.8.1 North America
8.8.1.1 Historical Trend (2018-2022)
8.8.1.2 Forecast Trend (2023-2028)
8.8.2 Europe
8.8.2.1 Historical Trend (2018-2022)
8.8.2.2 Forecast Trend (2023-2028)
8.8.3 Asia Pacific
8.8.3.1 Historical Trend (2018-2022)
8.8.3.2 Forecast Trend (2023-2028)
8.8.4 Latin America
8.8.4.1 Historical Trend (2018-2022)
8.8.4.2 Forecast Trend (2023-2028)
8.8.5 Middle East and Africa
8.8.5.1 Historical Trend (2018-2022)
8.8.5.2 Forecast Trend (2023-2028)
9 North America Genomics Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
10 Europe Genomics Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2022)
10.1.2 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Historical Trend (2018-2022)
10.2.2 Forecast Trend (2023-2028)
10.3 France
10.3.1 Historical Trend (2018-2022)
10.3.2 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Historical Trend (2018-2022)
10.4.2 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Genomics Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2022)
11.1.2 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Historical Trend (2018-2022)
11.2.2 Forecast Trend (2023-2028)
11.3 India
11.3.1 Historical Trend (2018-2022)
11.3.2 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Historical Trend (2018-2022)
11.4.2 Forecast Trend (2023-2028)
11.5 Australia
11.5.2 Historical Trend (2018-2022)
11.5.2 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Genomics Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2022)
12.1.2 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Historical Trend (2018-2022)
12.2.2 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Historical Trend (2018-2022)
12.3.2 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Genomics Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2022)
13.1.2 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2022)
13.2.2 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Historical Trend (2018-2022)
13.3.2 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Historical Trend (2018-2022)
13.4.2 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Illumina, Inc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 QIAGEN GmbH
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Eurofins GSC Lux SARL
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Agilent Technologies, Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Oxford Nanopore Technologies Limited
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 F. Hoffmann-La Roche
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Bio-Rad Laboratories, Inc.
16.2.7.1 Company Overview
16.2.7.2 Product Portfolio
16.2.7.3 Demographic Reach and Achievements
16.2.7.4 Certifications
16.2.8 BGI Group
16.2.8.1 Company Overview
16.2.8.2 Product Portfolio
16.2.8.3 Demographic Reach and Achievements
16.2.8.4 Certifications
16.2.9 Others
17 Key Trends and Developments in the Market

Companies Mentioned

  • Illumina, Inc.
  • Qiagen
  • Eurofins Scientific
  • Agilent Technologies, Inc.
  • Oxford Nanopore Technologies
  • F. Hoffmann-La Roche
  • Bio-Rad Laboratories, Inc.
  • BGI Group

Methodology

Loading
LOADING...

Table Information